Masafumi Miyagi

Recent publications · Crossref

5 total works indexed

1. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

   · 2020 · cited 6,449x

2. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

   · 2019 · cited 5,999x

3. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment

   · 2020 · cited 5,971x

4. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

   · 2018 · cited 4,220x

5. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

   · 2022 · cited 2,398x

via Crossref · CC0